A phase II Study of Electroporation Potentiated Immunotherapy in Liver Metastatic Pancreatic Cancer

Flak, Rasmus Virenfeldt (Project Coordinator)
Ladekarl, Morten (PI)
Poulsen, Laurids Østergaard (Project Coordinator)
Thorlacius-Ussing, Ole (Other)
Stender, Mogens Tornby (Other)
Detlefsen, Sönke (CoI)
Agger, Ralf (CoI)
Kofod-Olsen, Emil (CoI)
Wanders, Alkwin (CoI)

Project Details

Description

An investigator initiated clinical trial of combined immunotherapy (PD1-inhibitor) and irreversible electroporation in patients with metastatic pancreatic cancer.
The aim is to examine the efficacy and safety of the combined treatment.

Short title	Electroporation Potentiated Immunotherapy in Cancer – 1.st study
Acronym	EPIC-1
Status	Active
Effective start/end date	01/01/2021 → 31/12/2025

Keywords

pembrolizumab
irreversible electroporation
efficacy
safety
cancer
pancreatic cancer
pancreas
immunotherapy
ablation